TKL Research is a clinical research organization (CRO) with over 80 years of experience, specializing in providing comprehensive clinical trial management services across various phases, including Phase I through Phase IV. The company operates a 50-bed clinical pharmacology unit and multiple outpatient clinics, strategically located in the NY/NJ metro area, which allows them to access a diverse volunteer population. TKL Research emphasizes a streamlined approach to clinical trials, leveraging their extensive expertise to ensure efficient study management, from protocol development and site selection to data management and statistical analysis. Their commitment to quality and sponsor-focused services positions them as a premier choice for pharmaceutical, biotechnology, and medical device companies.

In addition to their full suite of CRO services, TKL Research offers stand-alone services tailored to specific client needs, such as medical writing, biostatistics, and pharmacovigilance. The organization prides itself on its ability to adapt to the evolving landscape of clinical research, ensuring that they are prepared for any challenges that may arise during the study process. With a dedicated team of experienced professionals overseeing various aspects of clinical operations, TKL Research is committed to delivering high-quality results and maintaining strong relationships with their sponsors, ultimately contributing to the success of clinical trials in diverse therapeutic areas.

United States

We are an independent, full-service, family-owned CRO specializing in dermatology since 1944. We manage global phase 2/3 trials in conjunction with our standalone phase I unit. Our structure and experience allow us to approach each and every study with agility and innovation, providing our sponsors with a truly bespoke turnkey solution. We are not your traditional CRO.

TKL Research

Company Details